Indefinite Delivery Contract SPE2DX15D9215

The federal contract IDV award SPE2DX15D9215 is a single-award Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,999,999 IDC was awarded by the Defense Logistics Agency (DLA) under the SPE2DX program, with an ultimate completion date of December 31, 2025.

The contract enables the DLA to issue firm fixed-price delivery orders to DMS Pharmaceutical Group for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. The products cover various categories such as injections, tablets, creams, auto-injectors, and specialty medications, supporting the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide. The task orders reviewed, valued at $2,932.40 and $8,209.50, were for the delivery of pharmaceutical products to the Park Ridge, Illinois location, with performance periods in 2023. This IDC positions DMS Pharmaceutical Group as a crucial supplier in the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare sites.